about
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencingSpread of artemisinin resistance in Plasmodium falciparum malariaA molecular marker of artemisinin-resistant Plasmodium falciparum malariaConservation and variability of dengue virus proteins: implications for vaccine designRule-based knowledge aggregation for large-scale protein sequence analysis of influenza A virusesGenomic analysis of local variation and recent evolution in Plasmodium vivax.A systematic bioinformatics approach for selection of epitope-based vaccine targetsConservation and Variability of West Nile Virus ProteinsGenetic architecture of artemisinin-resistant Plasmodium falciparumA genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in KenyaArtemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and AfricaCharacterization of Within-Host Plasmodium falciparum Diversity Using Next-Generation Sequence DataEvolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targetsIdentification of human-to-human transmissibility factors in PB2 proteins of influenza A by large-scale mutual information analysis.Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains.Effective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencingThe spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.Plasmodium falciparum founder populations in western Cambodia have reduced artemisinin sensitivity in vitro.Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance.Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast AsiaWest Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligandsChallenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia.Comparative genome-wide analysis and evolutionary history of haemoglobin-processing and haem detoxification enzymes in malarial parasitesMultiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia.Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in ThailandAnalysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.K13 Propeller Mutations in Plasmodium falciparum Populations in Regions of Malaria Endemicity in Vietnam from 2009 to 2016.ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale.ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization.Corrigendum: Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa.Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study.Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar.Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study.Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites.Genomic epidemiology of the current wave of artemisinin resistant malaria
P50
Q20901697-9D5C391B-4C45-4C5D-814D-723F06728851Q21032481-319E8411-7C10-4C68-A3CA-AEE74818014DQ21032481-EC718DC2-5A8C-43DB-8149-FB863EF7EA5DQ22061872-3AA6F60A-82DA-4931-9B3C-2918B49D1839Q24288762-873CADB0-82AF-4FAE-8746-4BB7A41EE5CCQ24657683-DE0A2E2D-6787-4D90-A6ED-DBF43DAF44BDQ27149930-A7BA6F78-49AD-41DA-9B12-5E5C84EB031CQ27481378-14E66725-F3A9-488A-BB18-2A2B4EC14962Q27488320-1252356E-F9EE-4389-85C4-4650207FAC28Q28030935-4FAA7997-E751-4A39-867D-F4A3EEEEA50BQ28031418-3FB0A6C5-4426-47A8-BBFE-EEE8B609F33CQ28608594-DFA65888-2A18-4E6D-936F-DF79539577F6Q30303389-99938E5F-1D9F-422B-BA52-CFA60824C995Q30303389-E6B4CD2A-C008-4784-BC30-0C9441510C83Q30366017-ACF056C6-AC30-40BE-A58E-7FAF840605F1Q30368054-C7FB75C2-485D-4A89-9853-3D13CDFA9F9FQ30384675-0F246FD3-17D8-4D85-8DE1-59ED87AC3150Q30385456-7BB5B9AB-7E1C-48C9-B349-128F421DF9D8Q30459215-BBE5BF2A-04F4-49A9-9B0F-4F0FA91C071AQ33607319-C21ED0A3-9C7B-4F73-993D-5B34495A4513Q33668137-939DAB3F-96BB-4E11-A486-0B217776B091Q34058328-C53738FE-F8F2-4763-B48E-03F9CB0FF630Q34453540-AC751593-C2FE-4859-866A-2501F1262207Q35102586-7AE86DAC-3A8C-454D-B655-23E90613E3E1Q36155428-8B45EEFC-A7AC-4A68-886F-DDCC3CF5BB0BQ36337171-259E4D2E-DFBF-42AC-B105-56DB8B834849Q36384456-F9969D8B-A70D-4A75-906A-37AD9D32756FQ36512312-76925D8A-E51B-47C7-B353-78200A974E5EQ36517516-5E0B656B-24B8-4BB1-9C26-0E14C780D73EQ37253966-1D0BDA7D-0662-486B-B2EF-F960B22DF51CQ37263344-0B7FE173-1EE7-4CE5-859F-565E9A1AB6D3Q37279757-76EB45A7-92D0-405E-B592-CA2663EB51E8Q37402952-5BDB65C8-8F54-461A-9CCA-ABEDECBFCA42Q37720813-33CCD081-6A5C-41B8-9616-034E201F053BQ38430058-F7BB9B53-63C8-4A39-9015-B8813806350AQ38510373-64640CF3-3E69-4227-BC5F-5A82DB210DD0Q43065194-C5EE1FD2-4284-4C05-A7A5-9E1661F481E9Q46818744-70B26D56-2384-4F38-B2E3-4A1BEDEEBD69Q47108422-59CC8C88-9C82-4669-AF8D-C6DD9581E88CQ48506962-2644791A-CE64-4B63-B03E-61599601985A
P50
description
bioinformatician
@en
bioinformaticus
@nl
name
Olivo Miotto
@ast
Olivo Miotto
@en
Olivo Miotto
@es
Olivo Miotto
@fr
Olivo Miotto
@nl
type
label
Olivo Miotto
@ast
Olivo Miotto
@en
Olivo Miotto
@es
Olivo Miotto
@fr
Olivo Miotto
@nl
prefLabel
Olivo Miotto
@ast
Olivo Miotto
@en
Olivo Miotto
@es
Olivo Miotto
@fr
Olivo Miotto
@nl
P106
P1960
4DjDScQAAAAJ
P21
P31
P496
0000-0001-8060-6771
P569
2000-01-01T00:00:00Z